WinX Capital
凯乘资本
WinX Capital (凯乘资本) is a China-based financial advisory boutique. According to 暗涌Waves, its founder is Zou Guowen (邹国文), who was running it as a healthcare-focused FA as of mid-2022 . The firm has served as exclusive financial adviser on multiple deals for Linear Capital's portfolio companies, including Aoxu Technology's nearly RMB 100 million Series A in early 2024 and DigiSight Medical's multi-million-yuan Pre-A+ round in mid-2023 . In both cases it was described as the "连续三轮" (three consecutive rounds) or repeat adviser, suggesting an ongoing relationship with those issuers. elsewhere's corpus does not cover its founding date, team size, or coverage beyond the healthcare sector.
AI-generated — may contain errors, please verify.
Coverage
Linear Capital's angel-round lead portfolio company, digital microfluidics technology platform Aoxu Technology, has completed a nearly RMB 100 million Series A funding round, with existing investor Linear Capital continuing to increase its support.
Recently, Foshan Aces Bio-Tech Co., Ltd. (hereinafter referred to as "Aces") announced the completion of a nearly RMB 100 million Series A financing round. **The round was led by Luxin Venture Capital, with existing shareholders Qiming Venture Partners, Linear Capital, and Tongchuang Weiyue continuing to increase their stakes.** WinX Capital served as the exclusive financial advisor for the third consecutive round.
线性资本·Linear Capital's Pre-A lead portfolio company **DigiSight Medical** has closed a multi-million-yuan Pre-A+ round, with existing investor Linear Capital continuing to back the company.
Accelerating clinical trials and R&D for ophthalmic and microsurgical robotic products.
线性资本·Spring Comes Quietly to Guomao
For China's investment industry at this moment, the eerily quiet Guomao feels like a metaphor.
暗涌Waves·
